Interferons and cancer

Posted By
Anonymous
4/11/2013 4:31pm
Activity
Replies: 3

Articles from journal.  Puzzled that they are describing interferon in this way.  Don't I understand that interferon is not a great success in melanoma? Perhaps I got this wrong?

___________________________________________________________________________________________________________________

 

Interferons and Their Antitumor Properties

Leonidas C. Platanias
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
143-144.
http://online.liebertpub.com/doi/abs/10.1089/jir.2013.0019?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
Biological Rationale and Clinical Use of Interferon in the Classical
BCR-ABL-Negative Myeloproliferative Neoplasms

Brady L. Stein and Ramon V. Tiu
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
145-153.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0120?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
Immunomodulatory Effects of Interferons in Malignancies

Joseph Bekisz, Yuki Sato, Chase Johnson, Syed R. Husain, Raj K. Puri,
and Kathryn C. Zoon
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
154-161.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0167?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
Interferons as Inducers of Apoptosis in Malignant Cells

Kevin P. Kotredes and Ana M. Gamero
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
162-170.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0110?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
Interferon-γ-Induced Necrosis: An Antitumor Biotherapeutic Perspective

Siddharth Balachandran and Gregory P. Adams
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
171-180.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0087?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
STAT Activation in Malignancies: Roles in Tumor Progression and in the
Generation of Antineoplastic Effects of IFNs

Ben X. Wang, Leonidas C. Platanias, and Eleanor N. Fish
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
181-188.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0154?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
Regulation of snoRNAs in Cancer: Close Encounters with Interferon

Shreeram C. Nallar and Dhananjaya V. Kalvakolanu
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
189-198.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0106?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
A Death-Promoting Role for ISG54/IFIT2

Nancy C. Reich
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
199-205.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0159?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
The Schlafen Family of Proteins and Their Regulation by Interferons

Evangelos Mavrommatis, Eleanor N. Fish, and Leonidas C. Platanias
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
206-210.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0133?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

------------------------------------------------------------------------
Hope and Fear for Interferon: The Receptor-Centric Outlook on the
Future of Interferon Therapy

Serge Y. Fuchs
Journal of Interferon & Cytokine Research, Vol. 33, No. 4, April 2013:
211-225.
http://online.liebertpub.com/doi/abs/10.1089/jir.2012.0117?ai=sk&ui=1i85m&af=T#utm_source=ETOC&utm_medium=email&utm_campaign=jir

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anonymous - (4/11/2013 - 9:35pm)

Could you give a summary of all these articles?  I only clicked on the last one and it was not positive about interferon.

mark1101 - (4/13/2013 - 9:39am)

My oncologist refers to Interferon as the "gold standard" treatment for, in particular, Stage III MM.

washoegal - (4/13/2013 - 2:47pm)

I saw nothing in the abstracts, at least, the referred to melanoma specifically.  Interferon is used for a variety of aliments.

 

Regarding the other post "Interferon - the "Gold Standard for Stage 3"  I believe that's because it's the ONLY approved treatment.

Life is too short to be anything but happy. Falling down is a part of life, getting back up is living.